Giulia Fiorini

Learn More
Helicobacter pylori infection remains widespread internationally, with a definite morbidity and mortality. The efficacy of standard 7-14 day triple therapies is decreasing, mainly due to increasing primary bacterial resistance to antibiotics. Currently, the most effective treatments are either the sequential regimen or the concomitant therapy. Different(More)
A systematic review on drugs absorption modifications after eradication in Helicobacter pylori positive patients undergoing replacement therapy A systematic review on drugs absorption modifications after eradication in Helicobacter pylori positive patients undergoing replacement therapy. Users may access full items free of charge; copies of full text items(More)
BACKGROUND AND AIMS Helicobacter pylori (H. pylori) infection has been suggested as a cause of impaired drug absorption. This infection leads to alteration of the gastric acid secretion that may change the conformational characteristics of drugs and their intestinal absorption leading to uncertainties about the dose to administer and the therapeutic(More)
  • 1